Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2014-03-12 PFIZER INC 10% owner Conversion · Series B-2 Preferred Stock −327,178 0
2014-03-12 PFIZER INC 10% owner Conversion · Series C Preferred Stock −301,005 0
2014-03-12 Main David President and CEO Returned to the company −9,459 $11.00 $104K 71,530
2014-03-12 Main David President and CEO Conversion −71,530 0
2014-03-12 Main David President and CEO Conversion +71,530 71,530
2014-03-12 Main David President and CEO Returned to the company · Common Exchangeable Shares −9,459 $11.00 $104K 0
2014-03-12 Main David President and CEO Conversion · Common Exchangeable Shares −71,530 0
2014-03-12 JOHNSON & JOHNSON 10% owner Conversion +1,392,094 1,392,094
2014-03-12 JOHNSON & JOHNSON 10% owner Conversion · Series A-1 Preferred Stock −255,681 0
2014-03-12 JOHNSON & JOHNSON 10% owner Conversion · Series A-2 Preferred Stock −170,454 0
2014-03-12 JOHNSON & JOHNSON 10% owner Conversion · Series B-1 Preferred Stock −293,884 0
2014-03-12 JOHNSON & JOHNSON 10% owner Conversion · Series B-2 Preferred Stock −292,532 0
2014-03-12 JOHNSON & JOHNSON 10% owner Conversion · Series C Preferred Stock −379,543 0
2014-03-06 LEVITT DANIEL J Director Grant or award · Stock Option (Right to Buy) +8,333 20,051
2014-03-06 Pelzer Robert Director Grant or award · Stock Option (Right to Buy) +8,333 14,843
2014-03-06 Bridger Gary Director Grant or award · Stock Option (Right to Buy) +8,333 8,333
2014-03-06 SIMPSON TODD E Director Grant or award · Stock Option (Right to Buy) +8,333 8,333

Page 27 of 27 · 537 trades